Loading company…
NephTech develops tools for monitoring vascular access in dialysis patients.
NephTech provides a vascular access measurement tool using sensors, signal algorithms, and cloud computing to help dialysis centers and home hemodialysis patients monitor early complications. Founded in 2016 by CEO James Lim, the company is based in Singapore and serves dialysis centers, patients, healthcare systems, government, and insurers.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in